Tempest Therapeutics, Inc. 8K

Tempest Therapeutics granted Lincoln Park Capital comprehensive registration rights to resell up to $50 million of Tempest common stock issuable under a new equity purchase agreement dated August 13, 2026.

Tempest Therapeutics, Inc. entered into a Registration Rights Agreement with Lincoln Park Capital Fund, LLC in connection with a Purchase Agreement dated August 13, 2026, under which Tempest will sell up to $50 million of common stock to Lincoln Park and must file and maintain one or more SEC registration statements on Form S-1 to register the resale of all commitment and purchase shares, use commercially reasonable efforts to keep those registrations effective, and provide Lincoln Park with related rights, covenants, and indemnification to facilitate continuous resales under Rule 415.

Filing Facts

CIK

1544227

Ticker

-

Form

8K

Source Type

sec

Accession

0001193125-26-349334

Alert Tier

6